About Precision Biomonitoring
Precision Biomonitoring is a company based in Ontario (United States) founded in 2016 by Mario Thomas was acquired by SQI Diagnostics in February 2022.. Precision Biomonitoring has raised $5 million across 1 funding round from investors including NGen and SQI Diagnostics. Precision Biomonitoring offers products and services including Game Bài, Slots Game, Live Game, Bắn Cá, and Thể Thao. Precision Biomonitoring operates in a competitive market with competitors including DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
- Headquarter Ontario, United States
- Founders Mario Thomas
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Suncity World
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 1 rounds
-
Latest Funding Round
$5 M (USD), Series A
Jun 02, 2020
-
Investors
NGen
& 1 more
-
Employee Count
Employee Count
-
Acquired by
SQI Diagnostics
(Feb 14, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Biomonitoring
Precision Biomonitoring offers a comprehensive portfolio of products and services, including Game Bài, Slots Game, Live Game, Bắn Cá, and Thể Thao. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Online platform for traditional card games like poker.
Digital slots with rewards and spinning mechanisms.
Real-time games like sicbo with live dealers.
Shooting games targeting sea creatures for rewards.
Platform for wagering on various sports events.
Funding Insights of Precision Biomonitoring
Precision Biomonitoring has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.0M
-
First Round
First Round
(02 Jun 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series A - Precision Biomonitoring | Valuation | NGen |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precision Biomonitoring
Precision Biomonitoring has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NGen and SQI Diagnostics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Advanced manufacturing and technology are advanced by NGen foundation.
|
Founded Year | Domain | Location | |
|
Multiplexed tests and automated systems for biological testing are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precision Biomonitoring
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Precision Biomonitoring
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precision Biomonitoring Comparisons
Competitors of Precision Biomonitoring
Precision Biomonitoring operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Molecular assays for disease detection are developed using proprietary technology.
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precision Biomonitoring
Frequently Asked Questions about Precision Biomonitoring
When was Precision Biomonitoring founded?
Precision Biomonitoring was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Where is Precision Biomonitoring located?
Precision Biomonitoring is headquartered in Ontario, United States. It is registered at Ontario, California, United States.
Who is the current CEO of Precision Biomonitoring?
Mario Thomas is the current CEO of Precision Biomonitoring. They have also founded this company.
Is Precision Biomonitoring a funded company?
Precision Biomonitoring is a funded company, having raised a total of $5M across 1 funding round to date. The company's 1st funding round was a Series A of $5M, raised on Jun 02, 2020.
What does Precision Biomonitoring do?
Precision Biomonitoring was founded in 2016 and is located in Ontario, United States. Operations focus on the molecular diagnostics sector, where kits and tools are developed for environmental DNA testing of aquatic species and pathogens. The TripleLock platform is employed for definitive species identification. Additionally, a handheld, battery-operated qPCR tool called Biomeme two3 is made available for field applications.
Who are the top competitors of Precision Biomonitoring?
Precision Biomonitoring's top competitors include DermTech, Biocartis and Molbio Diagnostics.
What products or services does Precision Biomonitoring offer?
Precision Biomonitoring offers Game Bài, Slots Game, Live Game, Bắn Cá, and Thể Thao.
Who are Precision Biomonitoring's investors?
Precision Biomonitoring has 2 investors. Key investors include NGen, and SQI Diagnostics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.